THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 88 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $31,764 | -18.9% | 3,069 | -15.0% | 0.00% | – |
Q1 2023 | $39,190 | +5.9% | 3,612 | +0.1% | 0.00% | – |
Q3 2022 | $37,000 | +146.7% | 3,608 | +115.4% | 0.00% | – |
Q2 2022 | $15,000 | -81.9% | 1,675 | -80.7% | 0.00% | – |
Q1 2022 | $83,000 | -83.3% | 8,675 | -80.7% | 0.00% | – |
Q4 2021 | $497,000 | +3.3% | 45,005 | -30.8% | 0.00% | -100.0% |
Q3 2021 | $481,000 | +2906.2% | 65,058 | +10113.2% | 0.00% | – |
Q4 2019 | $16,000 | -95.1% | 637 | -96.2% | 0.00% | -100.0% |
Q3 2019 | $326,000 | -66.5% | 16,737 | -71.9% | 0.00% | -66.7% |
Q2 2019 | $973,000 | +271.4% | 59,568 | +414.5% | 0.01% | +200.0% |
Q1 2019 | $262,000 | +870.4% | 11,577 | +952.5% | 0.00% | – |
Q1 2018 | $27,000 | -77.5% | 1,100 | -68.6% | 0.00% | -100.0% |
Q3 2017 | $120,000 | +140.0% | 3,500 | +154.2% | 0.00% | 0.0% |
Q3 2016 | $50,000 | -9.1% | 1,377 | -52.7% | 0.00% | 0.0% |
Q1 2016 | $55,000 | -5.2% | 2,912 | -17.1% | 0.00% | 0.0% |
Q4 2015 | $58,000 | -88.8% | 3,512 | -92.6% | 0.00% | -85.7% |
Q3 2015 | $520,000 | +5100.0% | 47,284 | +8038.4% | 0.01% | – |
Q1 2015 | $10,000 | -79.2% | 581 | -72.2% | 0.00% | -100.0% |
Q3 2014 | $48,000 | -57.1% | 2,093 | -40.6% | 0.00% | -50.0% |
Q2 2014 | $112,000 | – | 3,521 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chescapmanager LLC | 1,157,718 | $17,117,000 | 2.77% |
Baupost Group | 8,735,168 | $129,149,000 | 1.40% |
Orbimed Advisors | 6,219,110 | $91,950,000 | 1.16% |
Rubric Capital Management LP | 550,747 | $8,143,000 | 0.76% |
Cormorant Asset Management, LP | 650,072 | $9,611,000 | 0.37% |
Rock Springs Capital Management LP | 824,018 | $12,183,000 | 0.31% |
Virtus ETF Advisers LLC | 23,148 | $342,000 | 0.18% |
Tekla Capital Management LLC | 298,470 | $4,413,000 | 0.16% |
PEREGRINE CAPITAL MANAGEMENT LLC | 412,594 | $6,100,000 | 0.16% |
NJ State Employees Deferred Compensation Plan | 38,142 | $564,000 | 0.10% |